NEW HAVEN, CONN, March 13, 2000 -- Scientists from Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) and Yale University School of Medicine, both of New Haven, CT, today reported they have discovered that patients with acute coronary syndrome (ACS) have severe inflammation including significant production of injurious complement components in their coronary arteries. The report was made at the Scientific Sessions of the American College of Cardiology. Alexion's two C5 Complement Inhibitors, the humanized monoclonal antibody fragment 5G1.1-SC and the humanized monoclonal antibody 5G1.1, specifically block the production of harmful complement components and may be useful for treatment in this patient population.
"The current study demonstrates that harmful complement activation occurs specifically in the coronary arteries of patients with acute coronary syndrome," stated Michael W. Cleman, M.D., Professor of Medicine and Director of the Interventional Cardiology Service at Yale, and co-author of the study. "While current therapies for ACS patients are directed at attempting to improve coronary blood flow with anti-platelet and anti-clotting agents, an increasingly prominent literature demonstrates that ACS patients may also suffer from severe inflammation. The current findings add significantly to these previous observations by demonstrating that severe and injurious complement activation occurs specifically in the coronary circulation and in the culprit coronary artery in patients with ACS."
In the findings presented by Dr. Cleman and his colleagues at Yale and Alexion, blood samples from 11 patients with acute coronary syndrome and four patients with stable angina were obtained in order to measure production of activated complement directly in the heart. In patients with ACS, the level of activated complement increased by approximately 70% (P=.06) in the heart. In the patients with stable angina, the level of activated complement Page: 1 2 Related biology news :1
Contact: Dr. Leonard Bell
. Yale and Alexion report advance in spinal cord repair2
. Harvard and Alexion researchers report successful transplantation of immuneprotected neurons in primate model of Parkinsons disease3
. New hydrothermal vents discovered as South Pacific Odyssey research begins4
. Scientists discover potential new way to control drug-resistant bacteria5
. UAF scientists discover new marine habitat in Alaska6
. Researchers develop fast track way to discover how cells are regulated7
. Researchers discover why mutant gene causes colon cancer8
. A new protein is discovered to play a key role in cancer progression9
. Veterinarians discover first known case of canine distemper in a wild tiger10
. Scientists discover proteins involved in spread of HIV-1 infection11
. Protemix corporation announces discovery of way to repair hearts damaged by diabetes